Watchlist Price Alert

ArriVent BioPharma Inc. C... (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

19.98

-0.17 (-0.84%)

At close: May 12, 2025, 3:59 PM

20.30

1.60%

After-hours: May 12, 2025, 04:24 PM EDT

ArriVent BioPharma Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-94.31M	-93.72M	-86.2M	-83.09M	-74.59M	-61.91M	-56.97M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Interest Income	13.82M	12.67M	11.32M	8.51M	5.26M	3.33M	1.02M	n/a	n/a	n/a	n/a	n/a
Pretax Income	-80.49M	-81.05M	-74.89M	-74.58M	-69.33M	-58.58M	-55.95M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Net Income	-80.49M	-81.05M	-74.89M	-74.58M	-69.33M	-58.58M	-55.95M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Selling & General & Admin	15.3M	14.87M	13.16M	11.47M	9.71M	8.39M	7.64M	6.91M	6.47M	4.68M	3M	1.5M
Research & Development	79M	78.85M	73.04M	71.62M	64.88M	53.52M	49.33M	34.82M	30.43M	21.79M	11.7M	5.85M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	94.31M	93.72M	86.2M	83.09M	74.59M	61.91M	56.97M	41.73M	36.91M	26.46M	14.7M	7.35M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	94.31M	93.72M	86.2M	83.09M	74.59M	61.91M	56.97M	41.73M	36.91M	26.46M	14.7M	7.35M
Income Tax Expense	n/a	-23.12M	-39.83M	-39.83M	-52.01M	-39.33M	-34.38M	-34.38M	-22.21M	-11.77M	n/a	n/a
Shares Outstanding (Basic)	33.58M	33.58M	33.51M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	1.28M	1.28M
Shares Outstanding (Diluted)	33.58M	33.58M	33.51M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	33.49M	1.28M	1.28M
EPS (Basic)	-2.39	-2.41	-2.23	-2.22	-2.06	-1.74	-1.66	-6.78	-12.18	-11.87	-11.52	-5.76
EPS (Diluted)	-2.39	-2.41	-2.23	-2.22	-2.06	-1.74	-1.66	-6.78	-12.18	-11.87	-11.52	-5.76
EBITDA	-94.31M	-70.6M	-46.37M	-43.26M	-34.76M	-45.2M	-56.97M	-34.38M	-22.21M	-11.77M	n/a	n/a
EBIT	-94.31M	-93.72M	-86.2M	-83.09M	-74.59M	-61.91M	-56.97M	-41.73M	-36.91M	-26.46M	-14.7M	-7.35M
Depreciation & Amortization	n/a	23.12M	39.83M	39.83M	52.01M	39.33M	34.38M	41.73M	36.91M	26.46M	14.7M	7.35M